Department of Psychiatry, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Department of Psychiatry, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
J Clin Psychiatry. 2022 Jan 11;83(1):20m13692. doi: 10.4088/JCP.20m13692.
This study investigated differences in suicide and all-cause mortality from comorbid major depressive disorder (MDD) and type 2 diabetes mellitus (T2DM) depending on which was diagnosed first. A longitudinal administrative claims database including 2 million samples and national death registry data from 2000 through 2015 in Taiwan were used. Patients with newly diagnosed T2DM were identified and further classified into 3 groups: (1) MDD before T2DM, (2) T2DM without any diagnosis of MDD (from which matched controls were selected), and (3) MDD after T2DM, based on the sequential occurrence dates between incident T2DM and MDD. Multivariable Cox proportional hazard models were analyzed. Both the MDD before T2DM and MDD after T2DM groups had significantly higher risks of all-cause mortality (adjusted hazard ratio [AHR] = 1.21; 95% CI, 1.08-1.35 and AHR = 1.55; 95% CI, 1.45-1.66, respectively) and committed suicide (AHR = 5.05; 95% CI, 2.46-10.37and AHR = 14.32; 95% CI, 7.44-27.55, respectively) than their matched controls, while the MDD before T2DM and MDD after T2DM groups exhibited differences in mortality (significant; < .0001) and death by suicide (nonsignificant) The study findings indicated suicide and mortality rates were higher in both the MDD before and MDD after T2DM groups when compared with matched controls. Public health initiatives are needed to survey and treat comorbid MDD with T2DM. Furthermore, additional studies are needed to clarify the underlying pathophysiology of the association between MDD and T2DM to find better suicide prevention strategies among those high-risk patients who have comorbid T2DM and MDD.
这项研究调查了患有共病的重度抑郁症(MDD)和 2 型糖尿病(T2DM)的患者,根据哪种疾病先被诊断出,其自杀和全因死亡率的差异。该研究使用了来自台湾 2000 年至 2015 年的一项包含 200 万样本的纵向行政索赔数据库和国家死亡登记数据。确定了新诊断为 T2DM 的患者,并根据 T2DM 发病日期和 MDD 发病日期的先后顺序将其进一步分为三组:(1)T2DM 发病前患有 MDD,(2)T2DM 无任何 MDD 诊断(从中选择匹配的对照),(3)T2DM 发病后患有 MDD。采用多变量 Cox 比例风险模型进行分析。患有 T2DM 发病前 MDD 和 T2DM 发病后 MDD 的两组患者全因死亡率(调整后的危险比 [AHR]分别为 1.21;95%置信区间 [CI]为 1.08-1.35 和 AHR 为 1.55;95%CI 为 1.45-1.66)和自杀的风险均显著升高(AHR 分别为 5.05;95%CI 为 2.46-10.37 和 AHR 为 14.32;95%CI 为 7.44-27.55),而 T2DM 发病前 MDD 和 T2DM 发病后 MDD 两组患者在死亡率(显著;<0.0001)和自杀死亡(无统计学意义)方面存在差异。研究结果表明,与匹配的对照组相比,患有 T2DM 发病前 MDD 和 T2DM 发病后 MDD 的两组患者自杀和死亡率均较高。需要开展公共卫生计划,对 T2DM 合并 MDD 患者进行调查和治疗。此外,还需要开展更多研究以阐明 MDD 和 T2DM 之间关联的潜在病理生理学机制,以便在那些患有 T2DM 和 MDD 共病的高风险患者中找到更好的自杀预防策略。